Provention Bio Inc (the company became a subdivision of the company Sanofi ADR (SNY)) (PRVB) Event Aug. 04, 2022, 00:00 UTC (38% Neutral) PROVENTION BIO, INC. (PRVB) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:57 a.m. 🏢 Provention Bio Inc (the company became a subdivision of the company Sanofi ADR (SNY)) (PRVB) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-61.58M $-51.66M $-9.93M -19.22% 📈 Total Assets $135.62M $104.35M $31.27M +29.96% 📈 Total Liabilities $24.89M $25.67M $-785.00K -3.06% ↘️ Stockholders' Equity $158.02M $-239.22M $397.24M +166.06% 📈 Operating Income/Loss $-62.64M $-58.91M $-3.73M -6.33% 📈 R&D Expense $36.66M $33.93M $2.72M +8.02% 📉 Earningspersharebasic $-0.98 $-0.81 $-0.17 -20.99% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Provention Bio Inc (the company became a subdivision of the company Sanofi ADR (SNY)) (PRVB) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document